Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Implement Required Stop Orders for PRN Antianxiety Medication

Winfield, Kansas Survey Completed on 04-09-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to ensure that a resident receiving PRN antianxiety medication had appropriate stop orders in place, as required by facility policy. The resident had diagnoses including late-onset Alzheimer’s disease, pain, anxiety, severe cognitive impairment, delusions, and behavioral symptoms such as paranoia and agitation. The resident’s admission MDS documented severe cognitive impairment and behavioral symptoms, and the Behavioral Symptom CAA noted multiple episodes of paranoia and agitation, leading to an increased dose of Seroquel and lorazepam 1 mg PRN every four hours for anxiety. The care plan documented severely impaired cognition, depression, and use of antidepressant and antipsychotic medications for anxiety and paranoid thoughts, with interventions such as redirection and monitoring for worsening depression. Physician orders dated 01/30/26 and 03/27/26 directed staff to administer lorazepam 1 mg every four hours PRN for restlessness/agitation and topical lorazepam 2 mg/ml every four hours PRN if the oral dose was refused, both without stop dates. Another order dated 02/19/26 directed scheduled lorazepam 1 mg in the afternoon for anxiety disorder. The consultant pharmacist’s review on 02/09/26 recommended a stop date or GDR for the anxiolytic, but the physician declined, stating the resident was on hospice and receiving palliative care, without specifying a duration for continued PRN use. The administrative nurse responsible for monitoring psychotropic use confirmed that the physician had declined a stop date and was unsure about the need for a stop order for palliative residents. This was inconsistent with the facility’s Unnecessary Drugs and Psychotropic Drugs policy, which required limiting PRN psychotropic medications (other than antipsychotics) to 14 days unless a longer timeframe was deemed appropriate by the prescriber, thereby resulting in the cited deficiency.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙